Fanny Cardon

A highly virulent variant of HIV-1 circulating in the Netherlands

Chris Wymant, Daniela Bezemer, François Blanquart et al. · Science · 2022 · 75 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +14

Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial

Valérie Pourcher, Aude Desnoyer, Lambert Assoumou et al. · AIDS Research and Human Retroviruses · 2016 · 41 citations

Medicine, Pharmacology, Pharmacotherapy +17

Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study

Christine Katlama, Lambert Assoumou, Marc‐Antoine Valantin et al. · Journal of Antimicrobial Chemotherapy · 2019 · 37 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)

Sébastien Gallien, Amel Besseghir, Pierre Sellier et al. · Clinical Infectious Diseases · 2018 · 28 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection

Yves Lévy, Jean‐Daniel Lelièvre, Lambert Assoumou et al. · Annals of Internal Medicine · 2020 · 11 citations

Pharmacy, Pharmacology, Pharmacotherapy +17